These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 2531219)

  • 81. Synthesis and biological evaluation of the four isomers of technetium-99m labeled ethylenecysteamine cysteine ((99m)Tc-ECC), the mono-acid derivative of (99m)tc-L,L-ethylenedicysteine.
    Vanbilloen HP; Cleynhens BJ; Verbruggen AM
    Nucl Med Biol; 2000 Feb; 27(2):207-14. PubMed ID: 10773551
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Improvement in nuclear medicine diagnosis of kidney function using 99m technetium mercaptoacetyltriglycine (MAG3)].
    Erpenbach K; Ebert A; Wieler H
    Urologe A; 1991 Mar; 30(2):99-105. PubMed ID: 1829284
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Multicenter trial validation of a camera-based method to measure Tc-99m mercaptoacetyltriglycine, or Tc-99m MAG3, clearance.
    Taylor A; Manatunga A; Morton K; Reese L; Prato FS; Greenberg E; Folks R; Kemp BJ; Jones ME; Corrigan PE; Galt J; Eshima L
    Radiology; 1997 Jul; 204(1):47-54. PubMed ID: 9205222
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Quantitation of renal function using MAG3.
    Russell CD; Dubovsky EV
    J Nucl Med; 1991 Nov; 32(11):2061-3. PubMed ID: 1834813
    [No Abstract]   [Full Text] [Related]  

  • 85. Totally automatic definition of renal regions of interest from 99mTc-MAG3 renograms: validation in patients with normal kidneys and in patients with suspected renal obstruction.
    Garcia EV; Folks R; Pak S; Taylor A
    Nucl Med Commun; 2010 May; 31(5):366-74. PubMed ID: 20145580
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Technetium-99m-MAG3 renal studies in spinal cord injury patients: normal range, reproducibility, and change as a function of duration and level of injury.
    Klingensmith WC; Lammertse DP; Briggs DE; Smith WI; Roberts JF; Froelich JW; Sutherland JD
    Spinal Cord; 1996 Jun; 34(6):338-45. PubMed ID: 8963987
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Technetium-99m labeled renal function and imaging agents: III. Synthesis of 99mTc-MAG3 and biodistribution of by-products.
    Brandau W; Bubeck B; Eisenhut M; Taylor DM
    Int J Rad Appl Instrum A; 1988; 39(2):121-9. PubMed ID: 2833469
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Comparison of technetium-99m-ll-EC isomers in rats and humans.
    Taylor A; Hansen L; Eshima D; Malveaux E; Folks R; Shattuck L; Lipowska M; Marzilli LG
    J Nucl Med; 1997 May; 38(5):821-6. PubMed ID: 9170454
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Estimation of Tc-99m MAG3 clearance using camera-based methods without blood sampling.
    Inoue Y; Ohtomo K
    Clin Nucl Med; 2011 Nov; 36(11):1012-6. PubMed ID: 21975390
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Application of radioisotope renography with technetium-99m mercaptoacetyltriglycine on patients with spinal cord injuries.
    Bih LI; Changlai SP; Ho CC; Lee SP
    Arch Phys Med Rehabil; 1994 Sep; 75(9):982-6. PubMed ID: 8085934
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Technetium-99m-MAG3 and technetium-99m-DTPA: Renal clearance measured by the constant infusion technique - Old news?
    Østergaard AM; Langaa SS; Vrist MH; Mose FH; Bech JN; Fynbo CA; Theil J; Ejlersen JA
    Clin Physiol Funct Imaging; 2021 Nov; 41(6):488-496. PubMed ID: 34418886
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Phase II clinical study of 99mTc-MAG3].
    Ishii K; Ishibashi A; Tsukamoto E; Itoh K; Yamamoto K; Ishii Y; Kobayashi S; Takeda K; Nakagawa T; Hioki T
    Kaku Igaku; 1993 Apr; 30(4):411-22. PubMed ID: 8315891
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Radionuclide evaluation of renal function.
    Taylor A
    Crit Rev Diagn Imaging; 1991; 32(1):1-36. PubMed ID: 1645974
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Technetium-99m ethylene dicysteine: a new renal tubular function agent.
    Kabasakal L
    Eur J Nucl Med; 2000 Mar; 27(3):351-7. PubMed ID: 10774890
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Prediction of urinary excretion of technetium-99m-MAG3.
    Russell CD; Dubovsky EV; Taylor AT
    J Nucl Med; 1998 Jul; 39(7):1257-9. PubMed ID: 9669405
    [TBL] [Abstract][Full Text] [Related]  

  • 96. 99mTc-MAG3 kinetics in the normal pig. A comparison to 131I-OIH and 125I-iothalamate after single injection and during continuous infusion.
    Rehling M; Frøkiaer J; Poulsen EU; Marqversen J; Nielsen BV; Bacher T
    Clin Physiol; 1995 Jan; 15(1):57-71. PubMed ID: 7712693
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Abnormal MAG3 renal scintigraphy resulting from dehydration.
    Achong DM; Tenorio LE
    Clin Nucl Med; 2003 Aug; 28(8):683-4. PubMed ID: 12897661
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [A phase 2 clinical study of 99mTc-MAG3 injectable a dynamic renal imaging agent--evaluation of its safety, effectiveness and optimal dose].
    Torizuka K; Ishibashi A; Ikekubo K; Yamamoto K; Nishibuchi S
    Kaku Igaku; 1993 Nov; 30(11):1379-92. PubMed ID: 8277600
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Uterine technetium-99m mercaptoacetyltriglycine and diethylene triamine penta-acetic acid uptake in the scintigraphic evaluation of transplanted kidneys.
    Erbas B; Arinsoy T; Ugur O; Varoglu E; Arik N; Bekdik CF
    Eur J Nucl Med; 1992; 19(5):375-7. PubMed ID: 1535316
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [99Tcm]MAG3 gamma camera nephrography in epidemic nephritis.
    Paul R; Kiiliäinen H; Tarssanen L; Vorne M
    Nucl Med Commun; 1991 Jan; 12(1):15-25. PubMed ID: 1673780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.